NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 NorthStar Medical Radioisotopes, LLC a leading radiopharmaceutical company, today announced that it received notice of the U.S. Food & Drug Administration’s (FDA) acceptance of its Type II Drug Master…
Litmys and Konovo Form Partnership to Revolutionize Drug Development Intelligence for Life Sciences Companies Litmys, a life sciences commercial strategy consulting firm, specializing in the development of commercial readiness analytics, and Konovo, a technology-first healthcare intelligence company that accelerates access to…
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a…
Nick Dokoozlian Named Recipient of Triple Helix AgTech Leadership Prize Triple Helix Institute for Agriculture, Climate, and Society a nonprofit dedicated to building cross-sector engagement and public understanding around agriculture technology (AgTech), today announced Dr. Nick Dokoozlian as the recipient…
Promega Expands Forensic Portfolio with Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits Forensic casework laboratories will now have access to NimaGen’s IDseek® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced today between the two…
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…
Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu Genialis, the therapeutic intelligence company, announced it will present the first results from a new AI-based algorithm designed to distinguish between patients more likely to benefit from treatment with trastuzumab deruxtecan (Enhertu®, T-DXd).…
Transcat Expands into Latin America with Acquisition of SCM Metrology and Laboratories S.A. Transcat, Inc. a leading provider of test measurement, control and calibration, announced the acquisition of SCM Metrology and Laboratories S.A. (“SCM”), a privately-held calibration services provider based…
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system GE HealthCare integrates bkActiv™ with the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during…
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the…
IQM Announces First U.S. Quantum Technology Center in the University of Maryland’s Discovery District, Joining the Capital of Quantum Ecosystem IQM Quantum Computers, a global leader in superconducting quantum computing, and the Capital of Quantum (CoQ) announced today the establishment…
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen® Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today…